Glucagon for beta blocker overdose
Pro Research Analysisby 
Searched over 200M research papers
Glucagon for Beta Blocker Overdose: A Comprehensive Review
Introduction to Beta Blocker Overdose and Glucagon
Beta blocker overdose is a serious medical condition that can lead to life-threatening symptoms such as bradycardia, hypotension, and cardiogenic shock. Glucagon, a hormone traditionally used to treat hypoglycemia, has emerged as a potential antidote for beta blocker toxicity due to its ability to increase heart rate and myocardial contractility independently of beta-adrenergic receptors Boyd2003Peterson1984Shepherd2006.
Mechanism of Action of Glucagon in Beta Blocker Overdose
Glucagon exerts its effects by increasing cyclic AMP (cAMP) within the myocardium, which enhances both inotropic (force of contraction) and chronotropic (rate of contraction) properties of the heart. This mechanism bypasses the beta-adrenergic receptors, making glucagon effective even in the presence of beta blockers Peterson1984Fell2011White1999.
Clinical Evidence Supporting Glucagon Use
Human Studies and Case Reports
Several case reports and clinical reviews have documented the successful use of glucagon in treating severe beta blocker overdoses. For instance, two cases of profound beta blocker overdose were effectively managed with intravenous glucagon, demonstrating its ability to reverse cardiovascular depression Peterson1984Mi1985. Another review highlighted glucagon as a first-line antidote for symptomatic bradycardia and hypotension resulting from beta blocker toxicity .
Animal Studies
While human studies are limited, animal models have provided substantial evidence supporting glucagon's efficacy. In these studies, glucagon consistently increased heart rate and cardiac output, although its effect on mean arterial pressure was variable . Despite these findings, the survival benefit of glucagon in animal models remains unclear due to the lack of controlled human studies .
Dosage and Administration
The recommended dosage for glucagon in beta blocker overdose involves an initial intravenous loading dose of 50 micrograms/kg, followed by a continuous infusion ranging from 1 to 15 mg/h, titrated to the patient's response . This regimen has been shown to stabilize blood pressure and improve cardiac function in overdose scenarios .
Side Effects and Limitations
Common side effects of glucagon therapy include nausea, vomiting, hypokalemia, and hyperglycemia. These adverse effects necessitate careful monitoring of patients undergoing glucagon treatment Peterson1984Petersen2020. Additionally, the high cost and limited availability of glucagon may restrict its widespread clinical use .
Conclusion
Glucagon is a valuable antidote for beta blocker overdose, offering a mechanism of action that bypasses beta-adrenergic receptors and effectively increases heart rate and myocardial contractility. Despite the limited human studies, case reports and animal models provide compelling evidence for its use. However, clinicians must be mindful of its side effects and the practical challenges associated with its administration. Further research, particularly controlled human studies, is needed to solidify glucagon's role in the management of beta blocker toxicity.
Sources and full results
Most relevant research papers on this topic
DOI